BioNexus Gene Lab Corp Common stock (BGLC) had the best year between 2020 and 2022 by a US stock in 2021, returning 11,112,943.5%.

ASSET	YEAR	% RETURN
BioNexus Gene Lab Corp Common stock (BGLC)	2021	11,112,943.48%
ReShape Lifesciences (RSLS)	2021	10,933,156.47%
MDxHealth SA ADR (MDXH)	2021	865,354.55%
Integra Resources (ITRG)	2020	653,233.33%
MicroCloud Hologram (HOLO)	2021	577,362.44%
SS Innovations International Inc Common Stock (SSII)	2022	126,150%
Applied Digital (APLD)	2021	11,073.33%
Ascent Solar Technologies, Inc Common Stock (ASTI)	2020	7,900%
Bit Digital (BTBT)	2020	5,665.79%
Nuvve (NVVEW)	2020	5,366.67%
American Battery Technology Company Common Stock (ABAT)	2020	4,275%
NRx Pharmaceuticals (NRXPW)	2020	2,951.95%
Graf Industrial Corp Warrants (each warrant exercisable for one-half of one share of common stock each at an exercise price of $1150 per share) (GRAF.WT)	2020	2,944.83%
Novavax (NVAX)	2020	2,694.74%
HIVE Blockchain Technologies (HIVE)	2020	2,506.9%
Foremost Lithium Resource & Technology Ltd Common stock (FMST)	2022	2,400%
Trump Media & Technology (DJTWW)	2021	2,299.56%
Kaival Brands Innovations (KAVL)	2020	2,288.89%
Blink Charging (BLNK)	2020	2,186.1%
Destination XL (DXLG)	2021	2,067.94%
Zivo Bioscience (ZIVO)	2021	1,788.16%
GreenPower Motor (GP)	2020	1,777.94%
Fusion Fuel Green (HTOOW)	2020	1,747.22%
Guardforce AI (GFAI)	2021	1,628%
Clene (CLNNW)	2020	1,563.89%